Product image of Mupina (Mupirocin) supplied by GNH India

Mupina

Active Ingredient:
Mupirocin
Origin:
EU

Mupina (Mupirocin)

Mupirocin, the active ingredient in Mupina, is an antibiotic presented as a topical nasal preparation for intranasal use. It is employed to eradicate nasal carriage of Staphylococcus aureus in patients who are at risk of infection or undergoing procedures where bacterial colonisation could lead to complications.

GNH India supplies Mupina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mupirocin is an antibacterial agent used to target colonisation of the nasal passages by Staphylococcus aureus.

  • Nasal carriage of Staphylococcus aureus: eradicates colonisation of the nasal mucosa.
  • Pre‑operative decolonisation: reduces the risk of surgical site infections.
  • Hemodialysis patients: helps prevent transmission of Staphylococcus aureus.
  • Healthcare workers with carrier status: eliminates nasal colonisation to limit spread.

How It Works

  • Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for protein synthesis. By blocking the attachment of isoleucine to its tRNA, the drug prevents the formation of functional bacterial proteins, leading to a bacteriostatic effect at low concentrations and bactericidal activity at higher concentrations against susceptible Gram‑positive organisms, particularly Staphylococcus aureus.

Side Effects

Mupirocin is generally well tolerated when applied intranasally, but local and systemic reactions can occur.

Common Side Effects

  • Nasal irritation: mild burning or stinging sensation.
  • Itching: localized pruritus at the application site.
  • Dryness: dryness of the nasal mucosa.
  • Sneezing: transient increase in sneezing.
  • Mild headache: occasional tension‑type headache.
  • Local erythema: redness of the nasal skin.

Serious or Rare Side Effects

  • Allergic reaction: rash, swelling, or hives.
  • Anaphylaxis: severe, potentially life‑threatening hypersensitivity.
  • Severe dermatitis: intense inflammation of nasal tissue.
  • Stevens‑Johnson syndrome: rare mucocutaneous disorder.
  • Contact urticaria: localized hives upon contact.
  • Systemic infection: unlikely but reported with extensive use.

Precautions & Warnings

Before using Mupina, consider the following safety measures.

  • Pregnancy: consult a healthcare provider before use.
  • Breastfeeding: discuss potential risks with a physician.
  • Allergy: avoid if hypersensitive to mupirocin or formulation excipients.
  • Duration of therapy: limit to prescribed period to reduce resistance development.
  • Pediatric use: safety not fully established; use under medical supervision.
  • Store at room temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Mupirocin may interact with other agents applied to the nasal area or systemic medications.

Major Interactions (Avoid)

  • Concurrent use of other topical nasal antibiotics: may increase local irritation and resistance risk.
  • Nasal corticosteroids combined with mupirocin: could mask signs of infection.

Moderate Interactions (Monitor Closely)

  • Nasal decongestants: may enhance irritation.
  • Systemic antibiotics with overlapping spectrum: monitor for additive effects.
  • Antifungal nasal preparations: assess for combined mucosal effects.

Frequently Asked Questions

Mupina contains mupirocin and is prescribed to eradicate nasal carriage of Staphylococcus aureus. It is commonly used in patients who are carriers of the bacteria to reduce the risk of infection, especially before surgical procedures or in settings where transmission could be problematic.

Mupirocin blocks bacterial isoleucyl‑tRNA synthetase, an enzyme needed for protein synthesis. By preventing the attachment of isoleucine to its tRNA, the drug stops bacteria from producing essential proteins, leading to a bacteriostatic effect at low concentrations and a bactericidal effect at higher concentrations against susceptible organisms.

The dosage of Mupina is determined by the prescribing clinician based on the patient’s condition, age, and other factors. The prescriber will specify the amount to apply, frequency, and duration of treatment in the prescription.

Safety data for mupirocin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mupina.

To order Mupina, submit an enquiry on the product page at gnhindia.com, providing the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before responding with pricing, availability, shipping details and any necessary import documentation.

Mupirocin is the most widely used topical antibiotic for nasal decolonisation of Staphylococcus aureus due to its high potency and low resistance rates. Alternative agents, such as povidone‑iodine or chlorhexidine, have different mechanisms and may be less effective for persistent carriers.

Mupina should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and efficacy.

Mupina is applied intranasally as a thin layer of the ointment inside each nostril, usually using a clean fingertip or applicator. The prescriber will indicate the exact amount, frequency and length of treatment.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and severe dermatitis. Patients should seek immediate medical attention if they experience swelling, rash, difficulty breathing, or extensive skin reactions.

Mupina should not be used by individuals with a known hypersensitivity to mupirocin or any of the formulation’s excipients. It is also contraindicated in patients where the prescriber determines that the risks outweigh the benefits, such as certain severe allergic histories.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.